Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact. (2020)
Attributed to:
Technology supported systems for rapid impact on TB control
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkz564
PubMed Identifier: 32016320
Publication URI: http://europepmc.org/abstract/MED/32016320
Type: Journal Article/Review
Volume: 75
Parent Publication: The Journal of antimicrobial chemotherapy
Issue: 5
ISSN: 0305-7453